Toyoki Mori

3.9k total citations
101 papers, 3.4k citations indexed

About

Toyoki Mori is a scholar working on Molecular Biology, Social Psychology and Physiology. According to data from OpenAlex, Toyoki Mori has authored 101 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 25 papers in Social Psychology and 23 papers in Physiology. Recurrent topics in Toyoki Mori's work include Neuroendocrine regulation and behavior (25 papers), Electrolyte and hormonal disorders (18 papers) and Receptor Mechanisms and Signaling (12 papers). Toyoki Mori is often cited by papers focused on Neuroendocrine regulation and behavior (25 papers), Electrolyte and hormonal disorders (18 papers) and Receptor Mechanisms and Signaling (12 papers). Toyoki Mori collaborates with scholars based in Japan, Spain and United States. Toyoki Mori's co-authors include Yoshitaka Yamamura, Shigeki Nakamura, Michiaki Tominaga, Toshiyuki Onogawa, Hidenori Ogawa, Youichi Yabuuchi, Kazumi Kondo, Goro Miyakoda, Akito Tanoue and Hiroshi Yamashita and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Toyoki Mori

101 papers receiving 3.2k citations

Peers

Toyoki Mori
Comparison fields: 5 of 121
  • Molecular Biology 1.3k
  • Pulmonary and Respiratory Medicine 1.1k
  • Social Psychology 973
  • Cardiology and Cardiovascular Medicine 458
  • Cellular and Molecular Neuroscience 405
Atsuo Tahara Japan
Marc Pascal France
Michel B. Vallotton Switzerland
J. Paul Hieble United States
Th. Unger Germany
James H. Ludens United States
John R. Tippins United Kingdom
Robert E. Widdop Australia
A.L.A. Boura Australia
Ikunobu Muramatsu Japan
Atsuo Tahara Japan View profile →
Citations per field, relative to Toyoki Mori
Toyoki Mori · 1×
Citations per year, relative to Toyoki Mori
Toyoki Mori · 1×

Countries citing papers authored by Toyoki Mori

Since Specialization
Citations

This map shows the geographic impact of Toyoki Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toyoki Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toyoki Mori more than expected).

Fields of papers citing papers by Toyoki Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toyoki Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toyoki Mori. The network helps show where Toyoki Mori may publish in the future.

Co-authorship network of co-authors of Toyoki Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Toyoki Mori. A scholar is included among the top collaborators of Toyoki Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toyoki Mori. Toyoki Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Identification of aquaporin-5 and lipid rafts in human resting saliva and their release into cevimeline-stimulated saliva Biochimica et Biophysica Acta (BBA) - General Subjects Di Wang, Masahiro Muraguchi et al. 24
2 V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity Proceedings of the National Academy of Sciences Taka‐aki Koshimizu, Yoshihisa Nasa et al. 136
3 Direct positive chronotropic action by angiotensin II in the isolated mouse atrium Life Sciences Toyoki Mori, Ayako Hashimoto 9
4 Functional expression of human type I interferon receptors in the mouse liver Biochemical and Biophysical Research Communications Masahiro Muraguchi, Yasukazu Ohmoto et al. 1
5 Therapeutic Effects of Tolvaptan, a Potent, Selective Nonpeptide Vasopressin V2 Receptor Antagonist, in Rats with Acute and Chronic Severe Hyponatremia Endocrinology Yoshitaka Yamamura, Toshiyuki Onogawa et al. 30
6 Adrenal Influences on the Inhibitory Effects of Procaterol, a Selective Beta-Two-Adrenoceptor Agonist, on Antigen-Induced Airway Microvascular Leakage and Bronchoconstriction in Guinea Pigs Pharmacology Katsumi Ikezono, Toyoki Mori et al. 7
7 The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions Journal of Clinical Investigation Akito Tanoue, Shuji Ito et al. 192
8 A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsets Journal of Pharmacological and Toxicological Methods Masahiro Muraguchi, Yasukazu Ohmoto et al. 13
9 Antidiuretic Effects of a Novel Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Dogs Journal of Pharmacological Sciences Shigeki Nakamura, Takahiro Hirano et al. 5
10 Synthesis of oxypropanolamine derivatives of 3,4-dihydro-2H-1,4-benzoxazine, β-adrenergic affinity, inotropic, chronotropic and coronary vasodilating activities European Journal of Medicinal Chemistry Giancarlo Bruni, Paola Massarelli et al. 16
11 Differential properties of the optical‐isomers of pranidipine, a 1,4‐dihydropyridine calcium channel modulator Fundamental and Clinical Pharmacology Takahiro Hirano, Toyoki Mori et al. 5
12 Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain Neuroscience Letters Hisashi Kitagawa, Hitoshi Warita et al. 84
13 Induction of glial cell line-derived neurotrophic factor receptor proteins in cerebral cortex and striatum after permanent middle cerebral artery occlusion in rats Brain Research Hisashi Kitagawa, Chihoko Sasaki et al. 41
14 Pranidipine, a new 1, 4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta Molecular and Cellular Biochemistry Toyoki Mori, Tadayoshi Takeuchi et al. 16
15 Effects of vasodilators on the signal intensity of perfluorocarbon monitored by in vivo 19F-NMR spectroscopy Magnetic Resonance Imaging Takashi Imaizumi, Toyoki Mori et al. 4
16 Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist British Journal of Pharmacology Yoshitaka Yamamura, Hidenori Ogawa et al. 292
17 Novel positive inotropic agents: synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2(1H)-quinolinone derivatives Journal of Medicinal Chemistry Toyoki Mori, Tetsumi Hosokawa et al. 62
18 Histamine increases vascular tone and intracellular calcium level using both intracellular and extracellular calcium in porcine coronary arteries. The Japanese Journal of Pharmacology Toyoki Mori, Teruyuki Yanagisawa et al. 20
19 Pharmacological properties of buprenorphine, a new analgesic agent. Part II Folia Pharmacologica Japonica Takeshi Tani, H. Ishiyama et al. 2
20 Active rosette forming cells as a possible functional subpopulation of human peripheral T lymphocytes. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) Toyoki Mori, K Hattori et al. 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026